Summary
- Current Price
- As of today, LRMR price is $2.44, up +15.09% on
- Current Price All-Time High
- LRMR price is currently -95.59% below its historical high of $55.36 set on
- Market Cap
- LRMR current market cap is $253M, down -31.92% year-over-year
- Revenue
- LRMR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for LRMR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Larimar Therapeutics, Inc. |
| Ticker | NASDAQ: LRMR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | larimartx.com |
| Employees | 65 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.44 | ||
| Price, 1D Change | +15.09% | |
| $253M | ||
| - | ||
| - | ||
| 1.65 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.26 | ||
| EPS, 1Y Change | -72.02% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ZFGN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.26 | ||
| EPS Estimate | -$1.35 | N/A |
| EPS Est. Change | +40.30% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $2.44 | ||
| Price Target | $13.00 | - |
| Price Tgt. Change | +432.79% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.22 | -$1.32 | -8.05% | |
| -$1.99 | -$2.26 | -13.57% | |
| -$1.35 | N/A | +40.30% | |
| -$1.06 | N/A | +53.15% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $41.74M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -43.91% | ||
| -16.44% | ||
| -31.92% | ||
| +97.71% | ||
| 0.00% | ||
| 0.00% | ||
| -72.02% | ||
| -64.92% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.44 | ||
| $3.85 | ||
| $3.51 | ||
| $3.71 | ||
| $3.22 | ||
| -$0.41 | ||
| 1.65 | ||
| $0.21 | ||
| 36.64 | ||
| 123.39% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.26 | ||
| $0.00 | ||
| - | ||
| -$172.50M | ||
| - | ||
| -$165.67M | ||
| - | ||
| -$172.15M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 2.19 | ||
| 2.19 | ||
| - | ||
| - | ||
| -5.19 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.99 | ||
| -0.57 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $78.08M | ||
| $136.85M | ||
| $146.46M | ||
| $142.02M | ||
| $68.37M | ||
| $64.80M | ||
| $4.07M | ||
| $1.11M | ||
| $5.22M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $165.67M | ||
| $172.50M | ||
| $0.00 | ||
| $0.00 | ||
| $350.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$113.20M | ||
| $100.31M | ||
| $65.09M | ||
| $91.00K | ||
| -$113.29M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Baird | → | |
| JP Morgan | ||
| Wedbush | → | |
| Wedbush | → | |
| Wedbush | → | |
| Wedbush | → | |
| Citigroup | → | |
| Oppenheimer | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
No data
Screeners with LRMR
FAQ
- What is the ticker symbol for Larimar Therapeutics, Inc.?
- The ticker symbol for Larimar Therapeutics, Inc. is NASDAQ:LRMR
- Does Larimar Therapeutics, Inc. pay dividends?
- No, Larimar Therapeutics, Inc. does not pay dividends
- What sector is Larimar Therapeutics, Inc. in?
- Larimar Therapeutics, Inc. is in the Healthcare sector
- What industry is Larimar Therapeutics, Inc. in?
- Larimar Therapeutics, Inc. is in the Biotechnology industry
- What country is Larimar Therapeutics, Inc. based in?
- Larimar Therapeutics, Inc. is headquartered in United States
- When did Larimar Therapeutics, Inc. go public?
- Larimar Therapeutics, Inc. initial public offering (IPO) was on June 19, 2014
- Is Larimar Therapeutics, Inc. in the S&P 500?
- No, Larimar Therapeutics, Inc. is not included in the S&P 500 index
- Is Larimar Therapeutics, Inc. in the NASDAQ 100?
- No, Larimar Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Larimar Therapeutics, Inc. in the Dow Jones?
- No, Larimar Therapeutics, Inc. is not included in the Dow Jones index
- When was Larimar Therapeutics, Inc. last earnings report?
- Larimar Therapeutics, Inc.'s most recent earnings report was on August 4, 2026
- When does Larimar Therapeutics, Inc. report earnings?
- The next expected earnings date for Larimar Therapeutics, Inc. is November 5, 2026
Data Sources & References
- LRMR Official Website larimartx.com
- LRMR Profile on Yahoo Finance finance.yahoo.com/quote/LRMR
- LRMR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lrmr